Vanda Pharmaceuticals | Caixa E Equivalentes

Cash And Equivalent Alterar Data
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Acorda Therapeutics USD 25.27M 4.98M 2023-06
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Akebia Therapeutics USD 42.92M 3.6M 2023-12
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Arrowhead Research USD 58.22M 44.78M 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Bluebird Bio USD 165.35M 7.52M 2023-09
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Eli Lilly USD 2.38B 313.7M 2023-09
Enanta Pharmaceuticals USD 85.39M 9.79M 2023-09
Esperion Therapeutics USD 114.83M 23.64M 2023-09
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Heron Therapeutics USD 34.86M 21.4M 2023-09
Insmed USD 482.37M 4.74M 2023-12
Lexicon Pharmaceuticals USD 21.12M 235.62M 2023-09
Ligand Pharmaceuticals USD 22.95M 3.68M 2023-12
Merck USD 8.6B 2.94B 2023-09
Minerva Neurosciences USD 46.9M 4.89M 2023-09
Moderna USD 2.91B 25M 2023-12
Pfizer USD 3.15B 516M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Takeda JPY 318.05B 1.67B 2023-09
Teva Pharmaceutical Industries USD 2.25B 420M 2023-09
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Vanda Pharmaceuticals USD 150.03M 204.14M 2023-06
Veracyte USD 216.45M 13.99M 2023-12



Vanda Pharmaceuticals Caixa E Equivalentes - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.